These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 28238469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M, Wu W, Gao M, Fei Z.
    Cancer Biomark; 2017 Jul 04; 19(4):437-445. PubMed ID: 28582849
    [Abstract] [Full Text] [Related]

  • 3. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ, Su YR, Liu D, Xu DB, Zeng MS, Chen WK.
    J Surg Res; 2014 Dec 04; 192(2):487-93. PubMed ID: 24974154
    [Abstract] [Full Text] [Related]

  • 4. Metadherin Expression is Associated with Extrathyroidal Extension in Papillary Thyroid Cancer Patients.
    Moore RF, Sholl AB, Kidd L, Al-Qurayshi Z, Tsumagari K, Emejulu OM, Kholmatov R, Friedlander P, Abd Elmageed ZY, Kandil E.
    Ann Surg Oncol; 2016 Sep 04; 23(9):2883-8. PubMed ID: 27146414
    [Abstract] [Full Text] [Related]

  • 5. MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.
    Renaud F, Gnemmi V, Devos P, Aubert S, Crépin M, Coppin L, Ramdane N, Bouchindhomme B, d'Herbomez M, Van Seuningen I, Do Cao C, Pattou F, Carnaille B, Pigny P, Wémeau JL, Leteurtre E.
    Thyroid; 2014 Sep 04; 24(9):1375-84. PubMed ID: 25012490
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G, Zhou Y, Li T, Guo J, Zhou Z.
    J Int Med Res; 2013 Jun 04; 41(3):816-24. PubMed ID: 23685894
    [Abstract] [Full Text] [Related]

  • 7. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells.
    Xia S, Wang C, Ni X, Ni Z, Dong Y, Zhan W.
    Oncotarget; 2017 Jan 10; 8(2):2293-2306. PubMed ID: 27906682
    [Abstract] [Full Text] [Related]

  • 8. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL, Zhang H, Chen YL, Peng L.
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar 08; 46(3):160-165. PubMed ID: 28297755
    [Abstract] [Full Text] [Related]

  • 9. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
    Nunes LM, Ayres FM, Francescantonio IC, Saddi VA, Avelino MA, Alencar Rde C, Silva RC, Meneghini AJ, Wastowski IJ.
    Hum Immunol; 2013 Apr 08; 74(4):447-51. PubMed ID: 23261411
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
    Liu Y, Li L, Liu Z, Yuan Q, Lu X.
    Cancer Biomark; 2018 Apr 08; 22(4):727-732. PubMed ID: 29945344
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM.
    Clin Cancer Res; 2005 Nov 15; 11(22):8063-9. PubMed ID: 16299237
    [Abstract] [Full Text] [Related]

  • 13. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D, Keutgen XM, Crowley M, Filicori F, Aldailami H, Hoda R, Liu YF, Hoda RS, Scognamiglio T, Jin M, Fahey TJ, Zarnegar R.
    Ann Surg Oncol; 2012 Mar 15; 19(3):973-80. PubMed ID: 21879273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
    Pasquali D, Santoro A, Bufo P, Conzo G, Deery WJ, Renzullo A, Accardo G, Sacco V, Bellastella A, Pannone G.
    Thyroid; 2011 Apr 15; 21(4):391-9. PubMed ID: 21385081
    [Abstract] [Full Text] [Related]

  • 16. Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype.
    Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Inagaki M, Sanke T, Nakamura Y.
    J Clin Endocrinol Metab; 2011 Nov 15; 96(11):E1857-61. PubMed ID: 21880798
    [Abstract] [Full Text] [Related]

  • 17. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.
    Liu YM, Ying SP, Huang YR, Pan Y, Chen WJ, Ni LQ, Xu JY, Shen QY, Liang Y.
    World J Surg Oncol; 2016 Feb 04; 14(1):30. PubMed ID: 26846782
    [Abstract] [Full Text] [Related]

  • 18. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I.
    J Clin Pathol; 2011 Apr 04; 64(4):325-9. PubMed ID: 21296795
    [Abstract] [Full Text] [Related]

  • 19. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma.
    Yasuoka H, Nakamura Y, Zuo H, Tang W, Takamura Y, Miyauchi A, Nakamura M, Mori I, Kakudo K.
    Mod Pathol; 2005 Aug 04; 18(8):1127-33. PubMed ID: 15803188
    [Abstract] [Full Text] [Related]

  • 20. Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma.
    Choi YW, Kim YH, Lee J, Soh EY, Park TJ, Kim JH.
    Hum Pathol; 2015 Oct 04; 46(10):1557-65. PubMed ID: 26297257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.